Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Private equity firm jumps into vascular health with new investment
Vascular Technology, first founded 40 years ago, is planning on using the new funds to grow and expand its portfolio.
New report raises questions about data that helped heart drug gain FDA approval
Ticagrelor, an antiplatelet medication from AstraZeneca commonly prescribed by cardiologists, gained FDA approval back in 2011. The author of a new investigative report, however, is raising several concerns about the data used to secure that approval.
Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease
Semaglutide, tirzepatide and other GLP-1 drugs appear to provide significant value for patients with moderate PAD.
Angiographic catheters recalled due to safety risk
The new Class I recall includes nearly 27,000 devices that could potentially experience a harmful defect during use.
FDA clears blood clot removal system for treating pulmonary embolism
The Aventus Thrombectomy System was already cleared to treat blood clots in the peripheral arteries. This latest approval comes after positive results from an IDE study were published in JSCAI.

Example of ultrasound-assisted laser arterial plaque removal, which might be developed into a new type of less traumatic atherectomy system.Image courtesy of Rohit Singh.

New atherosclerosis treatment uses ultrasound-assisted lasers to break down plaque

The new technique is still in the development stage, but early research suggests it could provide clinicians with a new treatment option for breaking down arterial plaque.

Empagliflozin may reverse vascular aging, lower CVD risk

The SGLT2 inhibitor is already known as an effective medication for both type 2 diabetes and heart failure.

Anagrelide capsules FDA recall Teva Pharmaceuticals USA

FDA announces recall of platelet-reducing medication due to risk of clotting or other adverse cardiovascular outcomes

The medication failed a routine dissolution test, meaning it could lose its effectiveness.

TPV valves, CTO PCI and more: SCAI 2022 updates for interventional cardiologists

The first two days of SCAI 2022 were jam-packed with innovative technologies and late-breaking research.

Intravascular lithotripsy (IVL) Shockwave Medical PCI PAD CAD Disrupt PAD Disrupt CAD SCAI 2022

Intravascular lithotripsy tied to superior long-term PAD, PCI outcomes at SCAI 2022

Two separate sessions presented at SCAI 2022 focused on long-term outcomes associated with Shockwave Medical's IVL technology.

Medical device company raises $23M for fully absorbable vessel closure patches

Vivasure Medical will use the funds to advance clinical development and attempt to secure regulatory approval of its vessel closure devices.

New bleeding stroke guidelines highlight several common treatments that may be ineffective

The updated document, developed by the American Heart Association and American Stroke Association, also emphasizes the potential benefits of caregiver training and MR imaging.

When PPE is not enough: Improved shielding during EVAR linked to ‘dramatic reduction’ in radiation exposure

“Improving ancillary shielding barriers is paramount,” according to the authors of a brand new analysis.

Vascular & Endovascular

Private equity firm jumps into vascular health with new investment

New report raises questions about data that helped heart drug gain FDA approval

Popular obesity drugs limit amputations, heart issues among patients with peripheral artery disease

Angiographic catheters recalled due to safety risk

FDA clears blood clot removal system for treating pulmonary embolism